Showing results (261-270 of 392) with videos related to

Sort By:
Pageof 40
Biorxiv : the Preprint Server for Biology|June 26, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion ComplexUlrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis, et al.
Journal of Virology|July 29, 2011
Expression profiling of the intermediate and late stages of poxvirus replicationZhilong Yang, Sara E Reynolds, Craig A Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2005
The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodiesHua-Poo Su, Scott C Garman, Timothy J Allison, et al.
Journal of Virology|July 5, 2002
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surfaceRob J Center, Richard D Leapman, Jacob Lebowitz, et al.
Journal of Molecular Biology|March 21, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion ComplexUlrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis, et al.
Journal of Virology|December 13, 2002
Overcoming immunity to a viral vaccine by DNA priming before vector boostingZhi-yong Yang, Linda S Wyatt, Wing-Pui Kong, et al.
Elife|March 24, 2016
A SPOPL/Cullin-3 ubiquitin ligase complex regulates endocytic trafficking by targeting EPS15 at endosomesMichaela Gschweitl, Anna Ulbricht, Christopher A Barnes, et al.
Plos Pathogens|September 1, 2020
Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cellsChen Peng, Linda S Wyatt, Shira G Glushakow-Smith, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal DiseaseRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Pageof 40